Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.165 USD | -2.04% | +1.64% | -29.84% |
05-09 | PMV Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-12 | Jefferies Starts PMV Pharmaceuticals With Buy Rating, $5 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.84% | 114M | |
+39.89% | 54.04B | |
+43.57% | 41.96B | |
-1.13% | 41.92B | |
-7.59% | 28.35B | |
+12.60% | 26.35B | |
-22.07% | 19B | |
+7.74% | 13B | |
+28.35% | 12.28B | |
+25.15% | 12.19B |
- Stock Market
- Equities
- PMVP Stock
- News PMV Pharmaceuticals, Inc.
- PMV Pharmaceuticals Shares Fall After Early Trial Data on PC14586